Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men
NCT04142398 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-06-06
Summary
This research trial studies the incidence of human papilloma virus (HPV) infection and HPV-associated disease in screening Indian men who have sex with human immunodeficiency virus (HIV)-positive men. Gathering health information over time from Indian men who have sex with men (MSM) may help doctors determine how many HIV -positive MSM develop new HPV infections and how many HIV-positive MSM have HPV related disease.
Conditions
- HIV Infection
- Human Papillomavirus Infection
- Human Papillomavirus-Related Carcinoma
Interventions
- OTHER
-
Cytology Specimen Collection Procedure
Undergo penile skin cell and anal swab collection
- PROCEDURE
-
High Resolution Anoscopy with Biopsy
Undergo HRA with biopsy
- OTHER
-
Laboratory Biomarker Analysis
Correlative studies
- PROCEDURE
-
Medical Examination
Undergo anal and penile clinical exam
- PROCEDURE
-
Physical Examination
Undergo targeted physical exam
- OTHER
-
Questionnaire Administration
Ancillary studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
AIDS Malignancy Consortium
lead NETWORK
Principal Investigators
-
Joel Palefsky · AIDS Malignancy Consortium
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2027-04-30
- Primary Completion
- 2029-12-31
- Completion
- 2031-12-31
Countries
- United States
- India
Study Locations
More Related Trials
-
The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men
NCT02503111 ·Status: TERMINATED ·Phase: NA
-
The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women
NCT00006444 ·Status: COMPLETED
-
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
NCT00604175 ·Status: COMPLETED ·Phase: PHASE2
-
Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV
NCT01946139 ·Status: COMPLETED ·Phase: NA
-
Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies
NCT06144229 ·Status: ENROLLING_BY_INVITATION
-
Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women
NCT01461096 ·Status: COMPLETED ·Phase: PHASE3
-
HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL
NCT03947775 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study on Anal Human Papillomavirus Infection and Anal Intraepithelial Neoplasia Among Men Who Have Sex With Men in Indonesia, Malaysia, and Thailand
NCT02155231 ·Status: COMPLETED
-
Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
NCT07090174 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Immunogenicity of the Nonavalent Vaccine Against Human Papillomavirus in Men Infected by HIV Who Have Sex With Men. GESIDA 10017
NCT03626467 ·Status: COMPLETED ·Phase: PHASE4
-
Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men
NCT00428285 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men
NCT00865566 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
NCT01017172 ·Status: UNKNOWN ·Phase: PHASE4
-
Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV Infection
NCT03032575 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial in Adult Participants Without HIV and in Overall Good Health to Evaluate the Safety and Immunogenicity of CD4BS CH505M5 Pr-NP1 Followed by CH505 TF chTrimer Boost Both Adjuvanted With Either Lipid Nanoparticles (LNPs) or 3M-052-AF + Alum
NCT06267872 ·Status: WITHDRAWN ·Phase: PHASE1
-
Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.
NCT06436274 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial
NCT04265950 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
NCT02087384 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women
NCT00710593 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV
NCT05085145 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Safety and Immunogenicity of a Prophylactic HIV Vaccine Candidate
NCT05863585 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa
NCT00063778 ·Status: COMPLETED ·Phase: PHASE1
-
Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
NCT01923116 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
NCT05495906 ·Status: RECRUITING ·Phase: PHASE4
-
Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A Infection
NCT01102296 ·Status: COMPLETED ·Phase: NA